Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin.

Abstract:

:It is well known that intracellular antioxidant glutathione (GSH) plays major roles in the maintenance of redox status and defense of oxidative stress. Ras, a small GTP-binding protein, may send growth-stimulating message to the nucleus through downstream Rac oncoprotein and superoxide (O(2*-)). These findings led us to investigate the effects of GSH and melatonin, a free-radical scavenger, on Ras-Rac-O(2*-)-related growth signal transduction. Our results demonstrate that overexpression of the inducible Ha-ras oncogene by isopropyl-beta-D-thiogalactoside (IPTG) increases the levels of reactive oxygen species (ROS, including O(2*-) and hydrogen peroxide (H(2)O(2))) and GSH in an Ha-ras-transformed NIH/3T3 fibroblast cell line. On the contrary, melatonin significantly suppresses ras-triggered cell growth by inhibiting the increase of ROS and GSH. Moreover, severe apoptosis of this transformed cell line occurred when the cell redox balance between ROS and GSH was dramatically changed in the presence of IPTG and L-buthionine-[S,R]-sulfoximine (BSO, a specific inhibitor of GSH synthetase). That BSO-induced cell apoptosis needs Ras to increase the ROS level was demonstrated by the free-radical scavenger melatonin. It effectively blocked cell apoptosis, but cell growth was also slowed without affecting Ras expression. Based on our studies, two approaches can be applied to treating ras-related cancers. One is utilizing melatonin to suppress cancer cell proliferation, and the other is utilizing BSO to induce cancer-cell apoptosis. Cotreatment of ras-related cancer cells with melatonin and BSO stops cell growth as well as apoptosis. Whether these cancer cells will undergo further regression or become recurrent merits investigation.

journal_name

Oncogene

journal_title

Oncogene

authors

Chuang JI,Chang TY,Liu HS

doi

10.1038/sj.onc.1206289

subject

Has Abstract

pub_date

2003-03-06 00:00:00

pages

1349-57

issue

9

eissn

0950-9232

issn

1476-5594

pii

1206289

journal_volume

22

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.

    abstract::Esophageal cancer is one of the most lethal cancers worldwide with poor survival and limited therapeutic options. The discovery of microRNAs created a new milestone in cancer research. miR-377 is located in chromosome region 14q32, which is frequently deleted in esophageal squamous cell carcinoma (ESCC), but the biolo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.29

    authors: Li B,Xu WW,Han L,Chan KT,Tsao SW,Lee NPY,Law S,Xu LY,Li EM,Chan KW,Qin YR,Guan XY,He QY,Cheung ALM

    更新日期:2017-07-13 00:00:00

  • Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.

    abstract::There is an increasing interest in determining the role of ribosomal proteins (RPs) in the regulation of MDM2-p53 pathway in coordinating cellular response to stress. Herein, we report a novel regulatory role of ribosomal protein S25 (RPS25) in MDM2-mediated p53 degradation and a feedback regulation of S25 by p53. We ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.289

    authors: Zhang X,Wang W,Wang H,Wang MH,Xu W,Zhang R

    更新日期:2013-05-30 00:00:00

  • Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.

    abstract::Mutations of SMAD4/DPC4 are found in about 60% of human invasive pancreatic ductal adenocarcinomas (PDACs); yet, the manner in which SMAD4 deficiency enhances tumorigenesis remains elusive. Using a Cre-LoxP approach, we generated a mutant mouse carrying a targeted deletion of Smad4 in the pancreas. We showed that the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.375

    authors: Xu X,Ehdaie B,Ohara N,Yoshino T,Deng CX

    更新日期:2010-02-04 00:00:00

  • p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells.

    abstract::The present study was designed to elucidate the relationship between p53 and ceramide, both of which are involved in apoptotic signaling. Treatment of human glioma cells with etoposide caused apoptosis only in cells expressing functional p53. p53 activation was followed by the formation of reactive oxygen species (ROS...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204207

    authors: Sawada M,Nakashima S,Kiyono T,Nakagawa M,Yamada J,Yamakawa H,Banno Y,Shinoda J,Nishimura Y,Nozawa Y,Sakai N

    更新日期:2001-03-15 00:00:00

  • Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.

    abstract::The cdk2 gene has been identified as a human cdc2/CDC28-related gene that encodes a protein kinase essential for the G1/S transition in mammalian cells, but not for the G2/M transition, which requires Cdk1, another p34cdc2/CDC28 homolog. Novel potential functions of Cdk2 have been uncovered by using two potent and spe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203103

    authors: David-Pfeuty T

    更新日期:1999-12-09 00:00:00

  • Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.

    abstract::Integrins are adhesion receptors that mediate both cell-extracellular matrix and cell-cell interactions. It has also been reported that the loss of integrin alpha4 expression might be associated with metastasis in several cancers. However, the molecular mechanism for loss of their expression in cancers has not been ex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207470

    authors: Park J,Song SH,Kim TY,Choi MC,Jong HS,Kim TY,Lee JW,Kim NK,Kim WH,Bang YJ

    更新日期:2004-04-22 00:00:00

  • JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress.

    abstract::Ferritin is the major intracellular iron storage protein that sequesters excess free iron to minimize generation of iron-catalysed reactive oxygen species. We previously demonstrated that expression of ferritin heavy chain (ferritin H) was induced by pro-oxidants, which is a part of cellular antioxidant response to pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208901

    authors: Tsuji Y

    更新日期:2005-11-17 00:00:00

  • Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis.

    abstract::Mammalian target of rapamycin complex (mTORC) regulates a variety of cellular responses including proliferation, growth, differentiation and cell migration. In this study, we show that mammalian target of rapamycin complex 2 (mTORC2) regulates invasive cancer cell migration through selective activation of Akt1. Insuli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.22

    authors: Kim EK,Yun SJ,Ha JM,Kim YW,Jin IH,Yun J,Shin HK,Song SH,Kim JH,Lee JS,Kim CD,Bae SS

    更新日期:2011-06-30 00:00:00

  • Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.

    abstract::Temozolomide was recognized as the first-line therapy for glioblastoma to prolong the survival of patients noticeably, while recent clinical studies found that some patients were not sensitive to temozolomide treatment. The possible mechanisms seemed to be methylguanine-DNA-methyltransferase (MGMT), mismatch repair, P...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0596-2

    authors: Nie E,Miao F,Jin X,Wu W,Zhou X,Zeng A,Yu T,Zhi T,Shi Z,Wang Y,Zhang J,Liu N,You Y

    更新日期:2019-04-01 00:00:00

  • Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells.

    abstract::Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapy because of its relative tumor selectivity. However, many cancers including pancreatic cancer remain resistant towards TRAIL. To develop TRAIL for cancer therapy of pancreatic carcinoma, it will therefore b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209776

    authors: Vogler M,Dürr K,Jovanovic M,Debatin KM,Fulda S

    更新日期:2007-01-11 00:00:00

  • Tumor suppressor activity of RUNX3.

    abstract::Recent analyses have revealed that RUNX family members play important roles in both normal developmental processes and carcinogenesis. Of the three known RUNX family members, RUNX3 has been shown to be involved in neurogenesis of the dorsal root ganglia, T-cell differentiation and tumorigenesis of gastric epithelium. ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207286

    authors: Bae SC,Choi JK

    更新日期:2004-05-24 00:00:00

  • AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu.

    abstract::The anti-p185(her2/neu) peptidomimetic (AHNP) is a small exo-cyclic peptide derived from the anti-p185(her2/neu) rhumAb 4D5 (h4D5). AHNP mimics many but not all of the antitumor characteristics exhibited by h4D5. However, the pharmacokinetic profiles of AHNP are less than optimal for therapeutic or diagnostic purposes...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209745

    authors: Masuda K,Richter M,Song X,Berezov A,Masuda K,Murali R,Greene MI,Zhang H

    更新日期:2006-12-14 00:00:00

  • Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.

    abstract::This study examines whether the serine/threonine protein kinase, Akt, is involved in the crosstalk between the ErbB2 and estrogen receptor-alpha (ER-alpha) pathways. Treatment of MCF-7 cells with 10(-9) M heregulin-beta1 (HRG-beta1) resulted in a rapid phosphorylation of Akt and a 15-fold increase in Akt activity. Akt...

    journal_title:Oncogene

    pub_type: 杂志文章,收录出版

    doi:10.1038/sj.onc.1206311

    authors: Stoica GE,Franke TF,Wellstein A,Morgan E,Czubayko F,List HJ,Reiter R,Martin MB,Stoica A

    更新日期:2003-04-10 00:00:00

  • CHTM1, a novel metabolic marker deregulated in human malignancies.

    abstract::A better understanding of the link between cellular metabolism and tumorigenesis is needed. Here, we report characterization of a novel protein named coiled-coil helix tumor and metabolism 1 (CHTM1). We have found that CHTM1 is associated with cancer and cellular metabolism. CHTM1 localizes to mitochondria and cytosol...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0051-9

    authors: Babbar M,Huang Y,An J,Landas SK,Sheikh MS

    更新日期:2018-04-01 00:00:00

  • 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.

    abstract::Human WWOX gene encodes a proapoptotic WW domain-containing oxidoreductase WOX1 (also named WWOX, FOR2 or WWOXv1). Apoptotic and stress stimuli activate WOX1 via Tyr33 phosphorylation and nuclear translocation. WOX1 possesses a tetrad NSYK motif in the C-terminal short-chain alcohol dehydrogenase/reductase (SDR) domai...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208124

    authors: Chang NS,Schultz L,Hsu LJ,Lewis J,Su M,Sze CI

    更新日期:2005-01-20 00:00:00

  • Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.

    abstract::RAS-driven malignancies remain a major therapeutic challenge. The two-stage 7,12-dimethylbenz(a)anthracene (DMBA)/12-o-tetradecanoylphorbol-13-acetate (TPA) model of mouse skin carcinogenesis has been used to study mechanisms of epithelial tumor development by oncogenic Hras. We used mice with an Hras(G12V) knock-in a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.489

    authors: Chen X,Makarewicz JM,Knauf JA,Johnson LK,Fagin JA

    更新日期:2014-11-20 00:00:00

  • Murine WNT11 is a secreted glycoprotein that morphologically transforms mammary epithelial cells.

    abstract::Wnt genes encode a set of structurally related cell surface glycoproteins that appear to have roles in cell-cell signalling. The ectopic expression of several murine Wnt genes has been implicated in the transformation of mammary epithelial and the onset of mammary tumours. Wnt11 is expressed in the developing embryo i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Christiansen JH,Monkley SJ,Wainwright BJ

    更新日期:1996-06-20 00:00:00

  • Two regulatory domains are required for downregulation of c-myc transcription in differentiating U937 cells.

    abstract::In many differentiating cells, a reduction of c-myc proto-oncogene expression is a prerequisite for terminal differentiation. The downmodulation of c-myc in differentiating cells is due to at least two different mechanisms: (i) an elongation block to c-myc transcription activated during an early phase of differentiati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Skerka C,Zipfel PF,Siebenlist U

    更新日期:1993-08-01 00:00:00

  • Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase.

    abstract::We have identified a novel mechanism of cross-talk between cell signaling and metabolic pathways, whereby the signaling kinase p21-activated kinase 1 (Pak1) binds to, phosphorylates and enhances the enzymatic activity of phosphoglucomutase 1 (PGM), an important regulatory enzyme in cellular glucose utilization and ene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207969

    authors: Gururaj A,Barnes CJ,Vadlamudi RK,Kumar R

    更新日期:2004-10-21 00:00:00

  • The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest.

    abstract::We have previously shown that exogenous wild type p53 induces apoptosis in the Burkitt lymphoma line BL41 that carries endogenous mutant p53, using a temperature sensitive p53 construct expressed as mutant p53 at 37 degrees C and wild type p53 at 32 degrees C (Ramqvist et al., Oncogene, 8, 1495-1500, 1993). We also fo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Okan I,Wang Y,Chen F,Hu LF,Imreh S,Klein G,Wiman KG

    更新日期:1995-09-21 00:00:00

  • p73 is transcriptionally regulated by DNA damage, p53, and p73.

    abstract::p73 is a member of the p53 family. Recent studies have shown that DNA damage can stabilize p73 protein and enhance p73-mediated apoptosis in a c-Abl dependent manner. To determine what regulates p73 transcriptionally, we analysed the expression of p73 in several cell lines following genotoxic stresses. We found that p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204149

    authors: Chen X,Zheng Y,Zhu J,Jiang J,Wang J

    更新日期:2001-02-08 00:00:00

  • Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms.

    abstract::Mutant p53 frequently accumulates in cancer cells and promotes tumor cell invasion, as part of its gain of function. Its accumulation is partially due to enhanced stability, but little is known about how the mRNA levels of mutant p53 can be regulated. Likewise, the impact of cancer therapy on the levels of mutant p53 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.72

    authors: Bug M,Dobbelstein M

    更新日期:2011-08-18 00:00:00

  • Patterns of gene promoter methylation in squamous cell cancer of the head and neck.

    abstract::Promoter methylation is an important pathway in transcriptional silencing of known and candidate tumor suppressor genes in Head and Neck Squamous Cell Carcinoma (HNSCC). In order to study the association of tumor suppressor gene promoter methylation in HNSCC with patient clinical characteristics, especially alcohol co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205528

    authors: Hasegawa M,Nelson HH,Peters E,Ringstrom E,Posner M,Kelsey KT

    更新日期:2002-06-20 00:00:00

  • From identification of the BTK kinase to effective management of leukemia.

    abstract::BTK is a cytoplasmic protein-tyrosine kinase, whose corresponding gene was isolated in the early 1990s. BTK was initially identified by positional cloning of the gene causing X-linked agammaglobulinemia and independently in a search for new kinases. Given the phenotype of affected patients, namely lack of B-lymphocyte...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.343

    authors: Smith CI

    更新日期:2017-04-01 00:00:00

  • Restriction and complexity of Mcf2 proto-oncogene expression.

    abstract::MCF2/DBL is an X-linked proto-oncogene encoding a protein with a yet undetermined function. It can be activated in vitro by loss of 5' sequences in NIH3T3 bioassays; in vivo, deletion of the gene has been found in some hemophilia B patients. PCR analysis of its expression in mouse tissues shows a restriction to the go...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Galland F,Pirisi V,de Lapeyriere O,Birnbaum D

    更新日期:1991-05-01 00:00:00

  • The role of STATs in myeloid differentiation and leukemia.

    abstract::Myeloid differentiation is a highly regulated process governed by various cytokines, such as EPO, TPO, G-CSF, IL-3, IL-5 and GM-CSF. These cytokines act in part through activation of the STAT transcription factor family. In particular, various isoforms of STAT3 and STAT5 are activated during myeloid differentiation in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203479

    authors: Coffer PJ,Koenderman L,de Groot RP

    更新日期:2000-05-15 00:00:00

  • Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.

    abstract::SAP-1 (stomach cancer-associated protein tyrosine phosphatase-1) is a transmembrane-type protein tyrosine phosphatase that has been implicated as a negative regulator of integrin-mediated signaling. The potential role of this enzyme in hepatocarcinogenesis has now been investigated by examining its expression in 32 su...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206588

    authors: Nagano H,Noguchi T,Inagaki K,Yoon S,Matozaki T,Itoh H,Kasuga M,Hayashi Y

    更新日期:2003-07-24 00:00:00

  • TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.

    abstract::The family of tripartite-motif (TRIM) proteins are involved in diverse cellular processes, but are often characterized by critical protein-protein interactions necessary for their function. TRIM16 is induced in different cancer types, when the cancer cell is forced to proceed down a differentiation pathway. We have id...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.340

    authors: Marshall GM,Bell JL,Koach J,Tan O,Kim P,Malyukova A,Thomas W,Sekyere EO,Liu T,Cunningham AM,Tobias V,Norris MD,Haber M,Kavallaris M,Cheung BB

    更新日期:2010-11-18 00:00:00

  • Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

    abstract::To investigate the mechanisms of colorectal carcinogenesis, we searched for genes regulated by adenomatous polyposis coli gene product (APC) and identified a novel gene, termed HELAD1 (helicase, APC down-regulated 1). A recombinant polypeptide representing the ATPases associated with cellular activities (AAA) domain o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205751

    authors: Ishiguro H,Shimokawa T,Tsunoda T,Tanaka T,Fujii Y,Nakamura Y,Furukawa Y

    更新日期:2002-09-12 00:00:00

  • Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.

    abstract::Cyclin D1, a putative G1 cyclin, has been implicated in cell cycle control. The human cyclin D1 gene is located on chromosome 11q13 where DNA rearrangement and amplification have been detected in several types of human cancer. Previous studies demonstrated that the cyclin D1 gene is not only rearranged or amplified bu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Jiang W,Kahn SM,Zhou P,Zhang YJ,Cacace AM,Infante AS,Doi S,Santella RM,Weinstein IB

    更新日期:1993-12-01 00:00:00